🔎 Trials Near Me

Akèy › Timò Nèwo-endokrin › Minnesota › Rochester

Etid klinik pou Timò Nèwo-endokrin nan Rochester, MN

9 etid pou Timò Nèwo-endokrin ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Ap rekriteFaz 2/3
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Ap rekriteFaz 3
  • Investigative Site, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06881992

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Ap rekriteFaz 3
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07087054

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Ap rekriteFaz 1
  • Research Facility, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07165132

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Mayo Clinic in Rochester, Rochester
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Ap rekriteFaz 1/2
  • Crinetics Study Site, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07129252

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

Ap rekriteVolontè an sante akeyi
  • Mayo Clinic in Rochester, Rochester
Laj 18 a 85 · Tout sèks · Mizajou Jun 10, 2026 · NCT06788886

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic, Rochester
Laj 18 a 90 · Tout sèks · Mizajou May 14, 2026 · NCT05636618

Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)

Ap rekriteFaz 2
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT06926634

Etid Timò Nèwo-endokrin nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.